AJP - Regu AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol (March 15, 2007). doi:10.1152/ajpregu.00811.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/1/R528    most recent
00811.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bachteeva, V.
Right arrow Articles by Parnova, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bachteeva, V.
Right arrow Articles by Parnova, R.
Submitted on November 17, 2006
Accepted on March 9, 2007

Prostaglandin E2 inhibits vasotocin-induced osmotic water permeability in the frog urinary bladder by EP1-receptor-mediated activation of NO/cGMP pathway

Vera Bachteeva1, Ekaterina Fock1, Elena Lavrova1, Svetlana Nikolaeva1, Stepan Gambaryan2*, and Rimma Parnova1

1 Russian Academy of Sciences, I.M. Sechenov Institute of Evolutionary Physiology & Biochemistry, St. Petresburg, Russian Federation
2 University of Wuerzburg, Institute of Clinical Biochemistry and Pathobiochemistry, Wuerzburg, Germany; Russian Academy of Sciences, I.M. Sechenov Institute of Evolutionary Physiology & Biochemistry, St. Petresburg, Russian Federation

* To whom correspondence should be addressed. E-mail: gambaryan{at}klin-biochem.uni-wuerzburg.de.

PGE2 is a well-known inhibitor of the antidiuretic hormone-induced increase of osmotic water permeability (OWP) in different osmoregulatory epithelia; however, the mechanisms underlying this effect of PGE2 are not completely understood. Here we report that in the frog Rana temporaria urinary bladder, EP1 receptor-mediated inhibition of arginine-vasotocin (AVT)-induced OWP by PGE2 is attributed to increased generation of NO in epithelial cells. It was shown that the inhibitory effect of 17-phenyl-trinor-PGE2 (17-ph-PGE2), EP1 agonist, on AVT-induced OWP was significantly reduced in the presence of 7-nitroindazole (7-NI), nNOS inhibitor. NOS activity both in lysed and intact epithelial cells measured as a rate of convertion of L-[3H]-arginine to L-[3H]-citrullin was Ca2+-dependent and was inhibited by 7-NI. PGE2 and 17-ph-PGE2, but not M&B 28767 (EP3 agonist) or butaprost (EP2 agonist), stimulated NOS activity in epithelial cells. The above effect of PGE2 was abolished in the presence of SC 19220, EP1 antagonist. 7-NI reduced the stimulatory effect of 17-ph-PGE2 on NOS activity. 17-ph-PGE2 increased [Ca2+]i. and cGMP in epithelial cells. Western blot analysis revealed an nNOS expression in epithelial cells. These results show that the inhibitory effect of PGE2 on AVT-induced OWP in the frog urinary bladder is based at least partly on EP1-receptor-mediated activation of the NO/cGMP pathway, suggesting a novel crosstalk between AVT, PGE2, and nNOS that may be important in the regulation of water transport.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.